The firms are already taking the lion’s share of earnings from the market, as this week’s results will show
Praised for preventing hundreds of thousands of deaths and allowing a return to more normal life, Covid vaccines will also substantially benefit some pharmaceutical companies.
In June, analysts estimated the global market for the vaccines could be worth $70bn (£50bn) this year, but the figure could be even higher as the Delta variant of coronavirus spreads and scientists debate whether people will need booster shots.
Continue reading...from World news | The Guardian https://ift.tt/3ykUvkr
via IFTTT
via Blogger https://ift.tt/3fh40cZ
August 01, 2021 at 01:27AM
0 Comments